0000001 - Document - Cover link:presentationLink link:calculationLink link:definitionLink 0000002 - Statement - CONDENSED CONSOLIDATED BALANCE SHEETS (Unaudited) link:presentationLink link:calculationLink link:definitionLink 0000003 - Statement - CONDENSED CONSOLIDATED BALANCE SHEETS (Unaudited) (Parenthetical) link:presentationLink link:calculationLink link:definitionLink 0000004 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS AND COMPREHENSIVE INCOME (Unaudited) link:presentationLink link:calculationLink link:definitionLink 0000005 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY (Unaudited) link:presentationLink link:calculationLink link:definitionLink 0000006 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (Unaudited) link:presentationLink link:calculationLink link:definitionLink 0000007 - Disclosure - Interim Financial Statements link:presentationLink link:calculationLink link:definitionLink 0000008 - Disclosure - Product Sales link:presentationLink link:calculationLink link:definitionLink 0000009 - Disclosure - Collaboration, License, and Other Agreements link:presentationLink link:calculationLink link:definitionLink 0000010 - Disclosure - Net Income Per Share link:presentationLink link:calculationLink link:definitionLink 0000011 - Disclosure - Marketable Securities link:presentationLink link:calculationLink link:definitionLink 0000012 - Disclosure - Fair Value Measurements link:presentationLink link:calculationLink link:definitionLink 0000013 - Disclosure - Inventories link:presentationLink link:calculationLink link:definitionLink 0000014 - Disclosure - Income Taxes link:presentationLink link:calculationLink link:definitionLink 0000015 - Disclosure - Stockholders' Equity link:presentationLink link:calculationLink link:definitionLink 0000016 - Disclosure - Cash Flows link:presentationLink link:calculationLink link:definitionLink 0000017 - Disclosure - Legal Matters link:presentationLink link:calculationLink link:definitionLink 0000018 - Disclosure - Interim Financial Statements (Policies) link:presentationLink link:calculationLink link:definitionLink 0000019 - Disclosure - Product Sales (Tables) link:presentationLink link:calculationLink link:definitionLink 0000020 - Disclosure - Collaboration, License, and Other Agreements (Tables) link:presentationLink link:calculationLink link:definitionLink 0000021 - Disclosure - Net Income Per Share (Tables) link:presentationLink link:calculationLink link:definitionLink 0000022 - Disclosure - Marketable Securities (Tables) link:presentationLink link:calculationLink link:definitionLink 0000023 - Disclosure - Fair Value Measurements (Tables) link:presentationLink link:calculationLink link:definitionLink 0000024 - Disclosure - Inventories (Tables) link:presentationLink link:calculationLink link:definitionLink 0000025 - Disclosure - Stockholders' Equity (Tables) link:presentationLink link:calculationLink link:definitionLink 0000026 - Disclosure - Cash Flows (Tables) link:presentationLink link:calculationLink link:definitionLink 0000027 - Disclosure - Product Sales - Schedule of Net Product Sales (Details) link:presentationLink link:calculationLink link:definitionLink 0000028 - Disclosure - Product Sales - Narrative (Details) link:presentationLink link:calculationLink link:definitionLink 0000029 - Disclosure - Product Sales - Schedule of Concentration of Risk, by Risk Factor (Details) link:presentationLink link:calculationLink link:definitionLink 0000030 - Disclosure - Collaboration, License, and Other Agreements - Amounts Recognized In Statement of Operations with Sanofi (Details) link:presentationLink link:calculationLink link:definitionLink 0000031 - Disclosure - Collaboration, License, and Other Agreements - Sanofi, Antibody Narrative (Details) link:presentationLink link:calculationLink link:definitionLink 0000032 - Disclosure - Collaboration, License, and Other Agreements - Schedule of Contract Balances, Antibody Collaboration (Details) link:presentationLink link:calculationLink link:definitionLink 0000033 - Disclosure - Collaboration, License, and Other Agreements - Sanofi, Immuno-Oncology Narrative (Details) link:presentationLink link:calculationLink link:definitionLink 0000034 - Disclosure - Collaboration, License, and Other Agreements - Amounts Recognized in Statement of Operations with Bayer (Details) link:presentationLink link:calculationLink link:definitionLink 0000035 - Disclosure - Collaboration, License, and Other Agreements - Schedule of Contract Balances, Bayer Collaboration (Details) link:presentationLink link:calculationLink link:definitionLink 0000036 - Disclosure - Collaboration, License, and Other Agreements - Amounts Recognized in Statement of Operations with Roche (Details) link:presentationLink link:calculationLink link:definitionLink 0000037 - Disclosure - Collaboration, License, and Other Agreements - Schedule of Contract Balances - Roche (Details) link:presentationLink link:calculationLink link:definitionLink 0000038 - Disclosure - Collaboration, License, and Other Agreements - Sonoma Biotherapeutics, Inc. Narrative (Details) link:presentationLink link:calculationLink link:definitionLink 0000039 - Disclosure - Net Income Per Share - Schedule of Basic and Diluted Net Income Per Share (Details) link:presentationLink link:calculationLink link:definitionLink 0000040 - Disclosure - Net Income Per Share - Schedule of Antidilutive Securities Excluded From Computation (Details) link:presentationLink link:calculationLink link:definitionLink 0000041 - Disclosure - Marketable Securities - Schedule of Investments in Available For Sale Debt Securities (Details) link:presentationLink link:calculationLink link:definitionLink 0000042 - Disclosure - Marketable Securities - Schedule of Debt Securities Based on Contractual Maturity Dates (Details) link:presentationLink link:calculationLink link:definitionLink 0000043 - Disclosure - Marketable Securities - Schedule of Fair Value and Unrealized Losses of Debt Securities (Details) link:presentationLink link:calculationLink link:definitionLink 0000044 - Disclosure - Fair Value Measurements - Schedule of Assets Measured at Fair Value on a Recurring Basis (Details) link:presentationLink link:calculationLink link:definitionLink 0000045 - Disclosure - Fair Value Measurements - Narrative (Details) link:presentationLink link:calculationLink link:definitionLink 0000046 - Disclosure - Inventories - Schedule of Inventories (Details) link:presentationLink link:calculationLink link:definitionLink 0000047 - Disclosure - Inventories - Narrative (Details) link:presentationLink link:calculationLink link:definitionLink 0000048 - Disclosure - Income Taxes (Details) link:presentationLink link:calculationLink link:definitionLink 0000049 - Disclosure - Stockholders' Equity - Narrative (Details) link:presentationLink link:calculationLink link:definitionLink 0000050 - Disclosure - Stockholders' Equity - Schedule of Share Repurchases (Details) link:presentationLink link:calculationLink link:definitionLink 0000051 - Disclosure - Cash Flows - Schedule of Reconciliation of Cash, Cash Equivalents, and Restricted Cash (Details) link:presentationLink link:calculationLink link:definitionLink 0000052 - Disclosure - Cash Flows - Summary of Non-cash Investing and Financing Activities (Details) link:presentationLink link:calculationLink link:definitionLink 0000053 - Disclosure - Legal Matters (Details) link:presentationLink link:calculationLink link:definitionLink